SMTC Corp. (Nasdaq: SMTX) 55% HIGHER; reports Q4 EPS of $0.14, versus ($0.01) reported for the same period a year ago.
Revenue for the quarter was $51.24 million, compared to $55.26 million in Q408.Z BioSante Pharmaceuticals, Inc.
(NASDAQ: BPAX) 13% HIGHER; today announced positive results of a human clinical study that show that its GVAX Leukemia vaccine may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia (CML) patients taking the drug Gleevec...
Post new comment